The case for de-escalation in antimicrobial therapy: time to change our strategy in the management of septic shock?

Intensive Care Med. 2014 Feb;40(2):284-285. doi: 10.1007/s00134-013-3166-7. Epub 2013 Dec 6.

Authors

Matteo Bassetti¹, José-Artur Paiva², Robert G Masterton³

Affiliations

¹ Infectious Diseases Division, Santa Maria Misericordia Hospital, Udine, Italy.
² Emergency and Intensive Care Department, Centro Hospitalar Sao Joao, Porto Faculty of Medicine, University of Porto, Porto, Portugal.
³ Institute of Healthcare Associated Infection, University of the West of Scotland-University Hospital Crosshouse, 56A Lister Street, Kilmarnock, KA2 0BB, Ayrshire, UK. robert.masterton@uws.ac.uk.

PMID: 24310848
DOI: 10.1007/s00134-013-3166-7

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Antineoplastic Agents / adverse effects*
Female
Hospital Mortality*
Humans
Male
Neoplasms / drug therapy*
Neutropenia / drug therapy*
Sepsis / drug therapy*
Shock, Septic / mortality*

Substances

Anti-Bacterial Agents
Antineoplastic Agents